January 25, 2021: Johnson & Johnson board member Dr. Mark McClellan said, “if the clinical trial works out,” the company could significantly increase the nation’s COVID-19 vaccine supply available within the coming weeks.
Johnson & Johnson has enough data regarding its vaccine to begin analysis in the coming week or two, Dr. Fauci said on Thursday.
The important thing for the company’s vaccine is the large-scale clinical trial underway now, said McClellan.
“The independent scientists who are viewing that study should be taking a close look very shortly based on the results, and we’ll see how fast the vaccine could go forward,” McClellan said.
According to the Centers for Disease Control and Prevention, the U.S. averaged 883,000 jabs of the COVID-19 vaccine per day. However, under 50% of the 37,960,000 doses distributed have made their way into people’s arms. Minimum 12 states have reported vaccine shortages.
McClellan noted that the supply should increase, but probably not enough to keep up with many Americans wanting to get vaccinated.
“It’s going to be challenging, but I think the supply will be there over the next couple of months to vaccinate even more than 100 million Americans,” said McClellan.
On Thursday, President Joe Biden promised a “full-scale, wartime effort” to fight against the deadly pandemic and start vaccine production using the Defense Production Act.
“We’ve already identified suppliers and are working with them to move the plan forward,” Biden said.
We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.
September 26, 2023: On Monday, Japanese automaker Nissan revealed its dedication to transitioning to completely electric …
In an industry as competitive and fast-paced as Consumer Packaged Goods (CPG), standing out from the crowd requires innovation and adaptability. The cracks in the CPG supply chain were exposed long before the global pandemic struck, but the events of the past year only exacerbated the weaknesses.
Supply chain leaders, including VPs, often find themselves making bets with unknown financial consequences. Having started with largely infeasible plans generated by deterministic “one-number” planning systems, compounded by unexpected supply or demand disruptions, they are forced into last-minute adjustments to meet operational and financial goals.
Unsurprisingly, today’s supply chain faces numerous issues, including sustainability, technology, global economic and political instability, talent management, and supply chain resilience. Advanced forecasting algorithms and predictive analytics are used in supply chain management to help organizations of all sizes make better decisions by providing insights into what’s going on in their business at any given moment and predicting future trends.
Ensuring the right products are in the right place and at the right time is critical for companies also dealing with supply chain constraints and a high degree of variability. Uncertainty has become the name of the game and the only way to effectively optimize inventory through continuous, data-driven assessments, planning, and decision-making.
Food Huggers, a consumer brand that designs products to reduce waste at home, may be in an enviable position now but before they found Extensiv Order Manager, managing booming orders and staying on top of inventory was a huge operational challenge. The business has inventory spread across multiple geographically distributed warehouses, with orders received via multiple sales channels, including Shopify storefronts and Amazon.